Control Cancer p value
Biomarker Units Serum/  plasma median (range) median (range) cancer vs control
        all cancers  
PKM2 U/ml plasma 21.02 (11.26 - 73.3) 30.71 (5.81 - 98.80) 0.0006
IL8 pg/ml serum 11.26 (4.36 - 49.89) 15.77 (3.71 - 103.5) 0.0006
IL6 pg/ml serum 1.84 (0.95 - 55.80) 1.355 (0.93 - 4.740) 0.0006
IGFBP2 ng/ml serum 490.5 (188.7 - 1583) 699.2 (163.3 - 3698) 0.0011
Mac2BP ng/ml serum 7126 (3918 - 20150) 8350 (4290 - 40870) 0.0012
VEGFA pg/ml plasma 48.69 (31.42 - 387) 78.96 (33.29 - 910.1) 0.0013
TGFB1 pg/ml plasma 6034 (2070 - 21122) 8794 (1846 - 64230) 0.005
M65 U/L serum 312.6 (143.3 - 783.2) 358.4 (132.8 - 1032) 0.0051
IGF2 ng/ml serum 1399 (792.3 - 2230) 1221 (421.1 - 1864) 0.0052
TIMP1 ng/ml plasma 74.89 (42.53 - 131.3) 84.31(49.9 - 359.6) 0.0062
TIMP1 ng/ml serum 172.8 (74.3 - 314.4) 193.8 (98.6-449.4) 0.0129
MMP1 pg/ml serum 2090 (258 - 14300) 3350 (249 - 56000) 0.0226
OPN pg/ml plasma 4980 (868 - 29600) 7410 (425 - 297000) 0.033
TNF-alpha pg/ml serum 7.55 (1.55 - 13.21) 7.85 (3.09 - 26.67) 0.1092
TIMP2 ng/ml serum 82.5 (59.2 - 106.2) 77.6 (47.3 - 159.4) 0.1149
CEACAM6 ng/ml plasma 1.62 (0.60  - 3.54) 1.63 (0.60 - 7.99) 0.1344
MIP-1beta pg/ml serum 77.00 (37.30 - 369.0) 66.95 (35.8 - 1510) 0.1355
Dkk3 pg/ml plasma 58895 (37232 - 78500) 56473 (27726 - 75779) 0.3046
ENA-78 pg/ml serum 1275 (302 - 5180) 1240 (264 - 4450) 0.4717
MMP3 pg/ml serum 13250 (2280 - 37600) 11100 (2600 - 55500) 0.5033
TIMP2 ng/ml plasma 90.71 (64.06 - 129.7) 90.86 (53.78 - 172.3) 0.6593
MCP1 pg/ml serum 233.5 (80 - 526) 237.5 (20.3 - 795) 0.7915
MMP8 pg/ml serum 8720 (1510 - 21600) 8190 (1490 - 50600) 0.9344
M30 U/L serum 178.8 (85.7 - 500.1) 173.4 (87.17 - 901.6) 0.9791
Table 2: Summary of ELISA results for the biomarkers analysed in colorectal cancer and control patients ranked by p value.